| Paxneury 1 mg prolonged-release tablets EU/1/24/1908/001 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Paxneury 2 mg prolonged-release tablets EU/1/24/1908/002 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Paxneury 3 mg prolonged-release tablets EU/1/24/1908/003 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Paxneury 4 mg prolonged-release tablets EU/1/24/1908/004 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Paxneury 5 mg prolonged-release tablets EU/1/24/1908/005 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Paxneury 6 mg prolonged-release tablets EU/1/24/1908/006 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Paxneury 7 mg prolonged-release tablets EU/1/24/1908/007 |
Guanfacine hydrochloride |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Pazenir 5 mg/ml Powder for dispersion for infusion EU/1/18/1317/001 |
Paclitaxel |
Ratiopharm GmbH |
— |
| PecFent 100 micrograms/spray nasal spray, solution EU/1/10/644/001-002 |
Fentanyl, as citrate salt |
Grünenthal GmbH |
— |
| PecFent 400 micrograms/spray nasal spray, solution EU/1/10/644/003-004 |
Fentanyl, as citrate salt |
Grünenthal GmbH |
— |
| Pedea 5 mg/ml solution for injection EU/1/04/284/001 |
Ibuprofen |
Recordati Rare Diseases |
— |
| Pedippi 2 mg/ml powder for oral suspension PA1572/002/001 |
Omeprazole |
Xeolas Pharmaceuticals Limited |
Marketed |
| Pedippi 4 mg/ml powder for oral suspension PA1572/002/002 |
Omeprazole |
Xeolas Pharmaceuticals Limited |
Marketed |
| Pedismof emulsion for infusion PA2059/087/003 |
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamine acid |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Pedismof Neonate and Infant emulsion for infusion PA2059/087/002 |
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamine acid |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Pedismof Neonate emulsion for infusion PA2059/087/001 |
L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-glutamine acid |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Peditrace concentrate for solution for infusion PA2059/051/001 |
Zinc chloride, Copper chloride 2H2O, Manganese chloride 4H2O, Sodium selenite anhydrous, Sodium fluoride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Pedmarqsi 80 mg/mL solution for infusion EU/1/23/1734/001 |
Sodium thiosulfate |
Norgine B.V. |
— |
| Pegasys 135 micrograms solution for injection in pre-filled syringe EU/1/02/221/005-006 |
Peginterferon-alfa-2a |
pharmaand GmbH |
— |
| Pegasys 180 micrograms solution for injection EU/1/02/221/003-004 |
Peginterferon-alfa-2a |
pharmaand GmbH |
— |
| Pelgraz 6 mg Solution for injection EU/1/18/1313/001 |
Pegfilgrastim |
Accord Healthcare S.L.U. |
— |
| Pelmeg 6 mg solution for injection in pre-filled syringe EU/1/18/1328/001 |
Pegfilgrastim |
Mundipharma Corporation (Ireland) Limited |
— |
| Pemazyre 13.5 mg tablets EU/1/21/1535/005-006 |
Pemigatinib |
Incyte Biosciences Distribution B.V. |
— |
| Pemazyre 4.5 mg tablets EU/1/21/1535/001-002 |
Pemigatinib |
Incyte Biosciences Distribution B.V. |
— |
| Pemazyre 9 mg tablets EU/1/21/1535/003-004 |
Pemigatinib |
Incyte Biosciences Distribution B.V. |
— |
| Pemetrexed Accord 100 mg powder for concentrate for solution for infusion EU/1/15/1071/001 |
Pemetrexed disodium, Pemetrexed |
Accord Healthcare S.L.U. |
— |
| Pemetrexed Accord 1000 mg powder for concentrate for solution for infusion EU/1/15/1071/003 |
Pemetrexed, Pemetrexed disodium |
Accord Healthcare S.L.U. |
— |
| Pemetrexed Accord 25 mg/ml concentrate for solution for infusion EU/1/15/1071/004-007 |
Pemetrexed, Pemetrexed Disodium Hemipentahydrate |
Accord Healthcare S.L.U. |
— |
| Pemetrexed Accord 500 mg powder for concentrate for solution for infusion EU/1/15/1071/002 |
Pemetrexed disodium, Pemetrexed |
Accord Healthcare S.L.U. |
— |
| Pemetrexed Baxter 100 mg powder for concentrate for solution for infusion EU/1/22/1705/001 |
Pemetrexed disodium heptahydrate |
Baxter Holding B.V. |
— |
| Pemetrexed Baxter 500 mg powder for concentrate for solution for infusion EU/1/22/1705/002 |
Pemetrexed disodium heptahydrate |
Baxter Holding B.V. |
— |
| Pemetrexed Fresenius Kabi 100 mg powder for concentrate for solution for infusion EU/1/16/1115/001 |
Pemetrexed |
Fresenius Kabi Deutschland GmbH |
— |
| Pemetrexed Fresenius Kabi 25 mg/ml concentrate for solution for infusion EU/1/16/1115/003-005 |
Pemetrexed |
Fresenius Kabi Deutschland GmbH |
— |
| Pemetrexed Fresenius Kabi 500 mg powder for concentrate for solution for infusion EU/1/16/1115/002 |
Pemetrexed |
Fresenius Kabi Deutschland GmbH |
— |
| Pemetrexed Lilly EU/1/15/1034/001 |
Pemetrexed disodium heptahydrate |
Eli Lilly Nederland B.V. |
— |
| Pemetrexed Lilly EU/1/15/1034/002 |
Pemetrexed disodium heptahydrate |
Eli Lilly Nederland B.V. |
— |
| Pemetrexed medac 1,000 mg powder for concentrate for solution for infusion EU/1/15/1038/003 |
Pemetrexed |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Pemetrexed medac 100 mg powder for concentrate for solution for infusion EU/1/15/1038/001 |
Pemetrexed |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Pemetrexed medac 500 mg powder for concentrate for solution for infusion EU/1/15/1038/002 |
Pemetrexed |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion EU/1/15/1057/003 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion EU/1/17/1183/003 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion EU/1/15/1057/001 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion EU/1/17/1183/001 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion EU/1/15/1057/004-006 |
Pemetrexed Disodium Hemipentahydrate, Pemetrexed |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion EU/1/15/1057/002 |
Pemetrexed disodium |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion EU/1/17/1183/002 |
Pemetrexed ditromethamine |
Pfizer Europe MA EEIG |
— |
| Pemetrexed Seacross 100 mg powder for concentrate for solution for infusion PA22766/002/001 |
Pemetrexed |
Seacross Pharma (Europe) Limited |
Not marketed |
| Pemetrexed Seacross 500 mg powder for concentrate for solution for infusion PA22766/002/002 |
Pemetrexed |
Seacross Pharma (Europe) Limited |
Not marketed |
| Pepaxti 20 mg powder for concentrate for solution for infusion EU/1/22/1669/001 |
Melphalan Flufenamide Hydrochloride |
Oncopeptides AB |
— |
| Pergoveris (300 IU + 150 IU)/0.48 mL solution for injection in pre-filled pen EU/1/07/396/004 |
Lutropin alfa, Follitropin alfa |
Merck Europe B.V. |
— |